Examination of the 3 molecular forms of serum prostate specific antigen for distinguishing negative from positive biopsy: Relationship to transition zone volume

被引:68
作者
Stamey, TA [1 ]
Yemoto, CE [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA
关键词
prostate; prostate-specific antigen; biopsy; sensitivity and specificity; prostatic neoplasms;
D O I
10.1016/S0022-5347(05)67986-4
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: We evaluated the relative usefulness of total, free and complexed serum prostate specific antigen (PSA), and their ratios for distinguishing positive from negative biopsy of prostates in a university referral practice. Materials and Methods: We compared 90 consecutive men who had 2 sets of 6 negative systematic biopsies with 70 who had at least 5 mm. Of prostate cancer in systematic biopsies during the same period at our institution. Total prostate and transition zone volumes were determined by transrectal ultrasound. The Bayer,dagger DPC double dagger and Hybritech closed integral assays were performed to measure total, free and complexed serum PSA. Receiver operating characteristics curves were constructed for all forms of serum PSA and their ratios as well as prostate size to distinguish true positive (sensitivity) from false-positive (1 minus specificity) fractions. Results: Complexed PSA was only marginally better than total serum PSA. Free-to-total, complexed-to-total and prostate size had highly significant areas under the curves of greater than 80%. Free PSA only was better than complexed or total PSA. When factored by prostate volume, total PSA performed as well as the PSA ratios, and transition zone volume was consistently better than total prostate volume. DPC free-to-total ratios were equivalent to Hybritech ratios in all respects. Conclusions: Complexed PSA is only marginally better than total PSA for distinguishing negative from positive biopsy of prostates. It is inferior to free PSA and far less useful than free-to-total or complexed-to-total ratios. Prostate size is a decisive variable in men in whom we avoided the expected 25% false-negative biopsy rate in terms of specificity and hopefully avoided insignificant cancer in terms of sensitivity. In the future the performance of PSA serum markers should be related to a transition zone volume of less than 20, 20 to 60 and greater than 60 gm. when comparing assays to each other.
引用
收藏
页码:119 / 126
页数:8
相关论文
共 33 条
[1]  
ALTMEN DG, 1997, PRACTICAL STAT MED R, P410
[2]   Measurement of complexed PSA improves specificity for early detection of prostate cancer [J].
Brawer, MK ;
Meyer, GE ;
Letran, JL ;
Bankson, DD ;
Morris, DL ;
Yeung, KK ;
Allard, WJ .
UROLOGY, 1998, 52 (03) :372-378
[3]   Prospective evaluation of men with stage T1c adenocarcinoma of the prostate [J].
Carter, HB ;
Sauvageot, J ;
Walsh, PC ;
Epstein, JI .
JOURNAL OF UROLOGY, 1997, 157 (06) :2206-2209
[4]   Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease - A prospective multicenter clinical trial [J].
Catalona, WJ ;
Partin, AW ;
Slawin, KM ;
Brawer, MK ;
Flanigan, RC ;
Patel, A ;
Richie, JP ;
deKernion, JB ;
Walsh, PC ;
Scardino, PT ;
Lange, PH ;
Subong, ENP ;
Parson, RE ;
Gasior, GH ;
Loveland, KG ;
Southwick, PC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (19) :1542-1547
[5]   Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements [J].
Catalona, WJ ;
Smith, DS ;
Ornstein, DK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18) :1452-1455
[6]   COMPARISON OF DIGITAL RECTAL EXAMINATION AND SERUM PROSTATE-SPECIFIC ANTIGEN IN THE EARLY DETECTION OF PROSTATE-CANCER - RESULTS OF A MULTICENTER CLINICAL-TRIAL OF 6,630 MEN [J].
CATALONA, WJ ;
RICHIE, JP ;
AHMANN, FR ;
HUDSON, MA ;
SCARDINO, PT ;
FLANIGAN, RC ;
DEKERNION, JB ;
RATLIFF, TL ;
KAVOUSSI, LR ;
DALKIN, BL ;
WATERS, WB ;
MACFARLANE, MT ;
SOUTHWICK, PC .
JOURNAL OF UROLOGY, 1994, 151 (05) :1283-1290
[7]  
Chen ZX, 1997, J UROLOGY, V157, P2166, DOI 10.1016/S0022-5347(01)64704-9
[8]   CORE CANCER LENGTH IN ULTRASOUND-GUIDED SYSTEMATIC SEXTANT BIOPSIES - A PREOPERATIVE EVALUATION OF PROSTATE-CANCER VOLUME [J].
DIETRICK, DD ;
MCNEAL, JE ;
STAMEY, TA .
UROLOGY, 1995, 45 (06) :987-992
[9]   Prostate specific antigen density of the transition zone for early detection of prostate cancer [J].
Djavan, B ;
Zlotta, AR ;
Byttebier, G ;
Shariat, S ;
Omar, M ;
Schulman, CC ;
Marberger, M .
JOURNAL OF UROLOGY, 1998, 160 (02) :411-418
[10]   Prevalence and predictors of a positive repeat transrectal ultrasound guided needle biopsy of the prostate [J].
Fleshner, NE ;
OSullivan, M ;
Fair, WR .
JOURNAL OF UROLOGY, 1997, 158 (02) :505-508